Actively Recruiting
Augmented Momentary Personal Ecological Risk Evaluation Study of a Smartphone App for Suicide Risk Monitoring in Young Adults
Led by University of Washington · Updated on 2025-11-26
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
U
University of Washington
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a smartphone-based Ecological Momentary Assessment (EMA) prototype tool designed for young adults aged 16 to 30 who are experiencing suicidal thoughts. The study aims to co-design this tool together with patients and healthcare providers using human centered design methods. The goal is to develop an EMA system that supports suicide risk monitoring and management in outpatient primary care settings and to see if it is acceptable and usable as a clinical tool. Participants will download and use the AMPERE EMA app on their smartphones for two months. During this time, they will complete brief daily surveys about mood, activity, sleep, diet, substance use, and social support, as well as a weekly depression screener. The study includes training and support materials for clinical use and involves approximately 50 young adults receiving care for active suicidal ideation at the University of Washington Primary Care. Throughout the study, participants will complete three online surveys at enrollment, one month, and two months, covering demographics, suicidal ideation, self-injury, substance use, social support, and their experience using the EMA app. Researchers will measure the tool's acceptability, usability, and client satisfaction after two months. Secondary measures include coping related to suicide risk and the therapeutic alliance. The total participation time is two months, and safety and voluntary participation are monitored.
CONDITIONS
Brief Title
Augmented Momentary Personal Ecological Risk Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Young adults aged 16 to 30 years
- Receiving care for suicidal ideation at University of Washington Primary Care as identified by health records or recent suicide risk
- Ability to provide informed consent to participate
You will not qualify if you...
- Younger than 16 years or older than 30 years
- Non-English speaking
- No access to a smartphone
- Any medical, psychiatric condition or life situation that would make participation unsafe or involuntary
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - 2 months
Participants use the AMPERE EMA smartphone app to complete weekly and daily surveys on mood, activity, sleep, diet, substance use, and social support to monitor suicide risk.
3 online surveys at enrollment, 1 month, and 2 months
Trial Site Locations
Total: 1 location
1
University of Washington
Seattle, Washington, United States, 98195
Actively Recruiting
Research Team
M
Mindy Vredevoogd, MS
T
Tess Grover, BA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here